West Pharmaceutical Services, Inc. (WST)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Proprietary Products Revenue	2.62B	2.49B	2.33B
Proprietary Products Revenue Growth	5.27%	6.75%	-2.62%
West Vantage Products Revenue	597.60M	582.00M	558.70M
West Vantage Products Revenue Growth	2.68%	4.17%	1.12%
Revenue (Total)	3.22B	3.07B	2.89B
Revenue (Total) Growth	4.78%	6.25%	-1.92%

EBIT

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Proprietary Products Operating Profit	715.80M	657.20M	577.80M
Proprietary Products Operating Profit Growth	8.92%	13.74%	-18.63%
West Vantage Products Operating Profit	65.50M	63.40M	72.30M
West Vantage Products Operating Profit Growth	3.31%	-12.31%	0.28%
Operating Income (Other)	-126.30M	-135.70M	-80.20M
Operating Income (Total)	655.00M	584.90M	569.90M
Operating Income (Total) Growth	11.98%	2.63%	-15.70%

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Organic Net Sales Growth	4.30%	-1.50%

Updated Apr 23, 2026. Data Source: Fiscal.ai.